Archives of Medical Research
Volume 37, Issue 7 , Pages 848-853 , October 2006

Tumoral Cell mtDNA ∼8.9 kb Deletion Is More Common than Other Deletions in Gastric Cancer

  • Behnam Kamalidehghan

      Affiliations

    • Department of Medical Genetics, National Institute for Genetic Engineering and Biotechnology (NIGEB), Tehran, Iran
    • Department of Biomedical Sciences, Putra University Malaysia, Selangor, Malaysia
    • ,
  • Massoud Houshmand

      Affiliations

    • Department of Medical Genetics, National Institute for Genetic Engineering and Biotechnology (NIGEB), Tehran, Iran
    • Corresponding Author InformationAddress reprint requests to: Massoud Houshmand, Department of Medical Genetics, National Institute of Genetic Engineering and Biotechnology (NIGEB), Pajoohesh Blvd. Tehran-Karaj Highway, 17th Km., P.O. Box 14155-6343, Tehran, Iran
    • ,
  • Mehdi Shafa Shariat Panahi

      Affiliations

    • Department of Medical Genetics, National Institute for Genetic Engineering and Biotechnology (NIGEB), Tehran, Iran
    • ,
  • Mohammad Reza Abbaszadegan

      Affiliations

    • Department of Human Genetics, Bu-Ali Research Institute, Mashhad, Iran
    • ,
  • Patimah Ismail

      Affiliations

    • Department of Biomedical Sciences, Putra University Malaysia, Selangor, Malaysia
    • ,
  • Mahnaz Bagher Shiroudi

      Affiliations

    • Department of Medical Genetics, National Institute for Genetic Engineering and Biotechnology (NIGEB), Tehran, Iran

Received 17 December 2005 ,Accepted 3 March 2006.

References 

  1. Shenkar R, Navidi W, Tavaré S, Dang HM, Chomyn GA, Cortopassi G, et al. The mutation rate of the human mtDNA deletion mtDNA4977. Am J Hum Genet. 1996;50:772–780
  2. Correa PP, Haenszel W. Epidemiology of gastric cancer. In:  Correa P,  Haenszel W editor. Epidemiology of Cancer of the Digestive Tract. Vol. 2:The Hague: Martinus-Niijhoff; 1998;p. 58–84
  3. In:  Parkin DM,  Mujir CS,  Whelan SL,  Gao YT,  Ferlay J,  Powell J editor. Cancer Incidence in Five Continents. Vol. 6:Lyon: IARC Scientific Publication; 1992;p. 865–870No. 120
  4. Nadim A, Noorai M. Cancers. In:  Azizi F,  Hatami H,  Janghorbani M editor. Epidemiology and Control of Common Diseases in Iran. 1st ed.. Tehran: Eshtiagh; 2000;p. 216–217
  5. Naghavi M. Death report from 10 provinces in Iran. 1st ed.. Tehran: Ministry of Health; 2000;p. 384
  6. Wallace DC. Mitochondrial DNA sequence variation in human evolution and disease. Proc Natl Acad Sci USA. 1994;91:8739–8746
  7. Yakes FM, Houten BV. Mitochondrial DNA damage is more extensive and persists longer than nuclear DNA damage in human cells following oxidative stress. Proc Natl Acad Sci USA. 1997;94:514–519
  8. Croteau DL, Bohr V. Repair of oxidative damage to nuclear and mitochondrial DNA in mammalian cells. J Biol Chem. 1997;272:25409–25412
  9. Soslau G, Fuhrer JP, Nass MMK, Warren L. The effects of ethidium bromide on the membrane glycopeptides in control and virus transformed cells. J Biol Chem. 1974;249:3014–3020
  10. Morais R, Zinkewich PK, Parent M, Wang H, Babai F, Zollinger M. Tumor forming ability in athymic nude mice of human cell lines devoid of mitochondrial DNA. Cancer Res. 1994;54:3889–3896
  11. Bianchi MS, Bianchi NO, Bailiet G. Mitochondrial DNA mutations in normal and tumor tissue from breast cancer patients. Cytogenet Cell Gene. 1995;71:99–103
  12. Liang BC, Hays L. Mitochondrial DNA copy number changes in human gliomas. Cancer Lett. 1996;105:167–173
  13. Cavalli LR, Varella GM, Liang BC. Diminished tumorigenic phenotype after depletion of mitochondrial DNA. Cell Growth Differ. 1997;8:1189–1198
  14. Dani SU, Dani MAC, Simpson AJG. The common mitochondrial DNA deletion ΔmtDNA4977: shedding new light on the concept of a tumor suppressor mutation. Med Hypotheses. 2003;61:60–63
  15. Cortopassi GA, Arnheim N. Detection of a specific mitochondrial DNA deletion in tissues of older individuals. Nucleic Acids Res. 1990;18:6927–6933
  16. Corral DM, Stepian G, Shoffner JM, Lott MT, Kanter K, Wallace DC. Hypoxemia is associated with mitochondrial DNA damage and gene induction: implications for cardiac disease. JAMA. 1991;266:1812–1816
  17. Hattori K, Tanaka M, Sugiyama S, Obayashi T, Ito T, Satake T, et al. Age dependent increase in deleted mitochondrial DNA in the human heart: possible contributory factor to presbycardia. Am Heart J. 1991;121:1735–1742
  18. Zhu W, Qin W, Sauter ER. Large-scale mitochondrial DNA deletion mutations and nuclear genome instability in human breast cancer. Cancer Detect Prev. 2004;28:119–126
  19. Yin PH, Lee HC, Chau GY, Wu YT, Li SH, Lui WY, et al. Alteration of the copy number and deletion of mitochondrial DNA in human hepatocellular carcinoma. Br J Cancer. 2004;90:2390–2396
  20. Kotake K, Nonami T, Kurokawa T, Nakao A, Murakami T, Shimomura Y. Human livers with cirrhosis and hepatocellular carcinoma have less mitochondrial DNA deletion than normal human livers. Life Sci. 1999;64:1785–1791
  21. Lee HC, Yin PH, Yu TN, Chang YD, Hsu WC, Kao SY, et al. Accumulation of mitochondrial DNA deletions in human oral tissues—effects of betel quid chewing and oral cancer. Mutat Res. 2001;493(1–2):67–74
  22. Maximo V, Soares P, Seruca R, Rocha AS, Castro P, Sobrinho-Simoes M. Microsatellite instability, mitochondrial DNA large deletions, and mitochondrial DNA mutations in gastric carcinoma. Genes Chromosomes Cancer. 2001;32:136–143
  23. Lewis PD, Baxter P, Paul Griffiths A, Parry JM, Skibinski DO. Detection of damage to the mitochondrial genome in the oncocytic cells of Warthin's tumour. J Pathol. 2000;191:274–281
  24. Abnet CC, Huppi K, Carrera A, Armistead D, McKenney K, Hu N, et al. Control region mutations and the 'common deletion' are frequent in the mitochondrial DNA of patients with esophageal squamous cell carcinoma. BMC Cancer. 2004;4:30
  25. Dani MA, Dani SU, Lima SP, Martinez A, Rossi BM, Soares F, et al. Less Delta mtDNA4977 than normal in various types of tumors suggests that cancer cells are essentially free of this mutation. Genet Mol Res. 2004;30(3):395–409
  26. Fukushima S, Honda K, Awane M, Yamamoto E, Takeda R, Kaneko I, et al. The frequency of 4977 base pair deletion of mitochondrial DNA in various types of liver disease and in normal liver. Hepatology. 1995;21:1547–1551
  27. Shi SR, Cote RJ, Wu L, Liu C, Datar R, Shi Y, et al. DNA extraction from archival formalin-fixed, paraffin-embedded tissue sections based on the antigen retrieval principle: heating under the influence of pH. J Histochem Cytochem. 2002;50:1005–1011
  28. Fang DC, Wang RQ, Yang SM, Yang JM, Liu HF, Peng GY, et al. Mutation and methylation of hMLH1 in gastric carcinomas with microsatellite instability. World J Gastroenterol. 2003;9:655–659
  29. Fang DC, Luo YH, Yang SM, Li XA, Ling XL, Fang L. Mutation analysis of APC gene in gastric cancer with microsatellite instability. World J Gastroenterol. 2002;8:787–791
  30. Fliss MS, Usadel H, Caballero OL, Wu L, Buta MR, Eleff SM, et al. Facile detection of mitochondrial DNA mutations in tumors and bodily fluids. Science. 2000;287:2017–2019
  31. Richard SM, Bailliet G, Paez GL, Bianchi MS, Peltomaki P, Bianchi NO. Nuclear and mitochondrial genome instability in human breast cancer. Cancer Res. 2000;60:4231–4237
  32. Yeh JJ, Lunetta KL, van Orsouw NJ, Moore FD, Mutter GL, Vijg J, et al. Somatic mitochondrial DNA (mtDNA) mutations in papillary thyroid carcinomas and differential mtDNA sequence variants in cases with thyroid tumours. Oncogene. 2000;19:2060–2066
  33. Habano W, Sugai T, Yoshida T, Nakamura S. Mitochondrial gene mutation, but not large-scale deletion, is a feature of colorectal carcinomas with mitochondrial microsatellite instability. Int J Cancer. 1999;83:625–629
  34. Hochhauser D. Relevance of mitochondrial DNA in cancer. Lancet. 2000;356:181–182
  35. Liu MR, Pan KF, Li ZF, Wang Y, Deng DJ, Zhang L, et al. Rapid screening mitochondrial DNA mutation by using denaturing high-performance liquid chromatography. World J Gastroenterol. 2002;8:426–430
  36. Wu CW, Yin PH, Hung WY, Li AF, Li SH, Chi CW, et al. Mitochondrial DNA mutations and mitochondrial DNA depletion in gastric cancer. Genes Chromosomes Cancer. 2005;44:19–28
  37. Alonso A, Martin P, Albarran C, Aquilera B, Garcia O, Guzman A, et al. Detection of somatic mutations in the mitochondrial DNA control region of colorectal and gastric tumors by heteroduplex and single-strand conformation analysis. Electrophoresis. 1997;18:682–685
  38. Burgart LJ, Zheng J, Shu Q, Strickler JG, Shibata D. Somatic mitochondrial mutation in gastric cancer. Am J Pathol. 1995;147:1105–1111
  39. Wu MS, Shun CT, Wang HP, Sheu JC, Lee WJ, Wang TH, et al. Genetic alterations in gastric cancer: relation to histological subtypes, tumor stage, and Helicobacter pylori infection. Gastroenterology. 1997;112:1457–1465
  40. Endoh Y, Sakata K, Tamura G, Ohmura K, Ajioka Y, Watanabe H, et al. Cellular phenotypes of differentiated-type adenocarcinomas and precancerous lesions of the stomach are dependent on the genetic pathways. J Pathol. 2000;191:257–263
  41. Ohmura K, Tamura G, Endoh Y, Sakata K, Takahashi T, Motoyama T. Microsatellite alterations in differentiated-type adenocarcinomas and precancerous lesions of the stomach with special reference to cellular phenotype. Hum Pathol. 2000;31:1031–1035
  42. Xian LL, Dian CF, Rong QW, Shi MY, Li F. Mitochondrial microsatellite instability in gastric cancer and its precancerous lesions. World J Gastroenterol. 2004;10:800–803
  43. Hirano M, Marti R, Ferreiro-Barros C, Vila MR, Tadesse S, Nishigaki Y, et al. Defects of intergenomic communication:autosomal disorders that cause multiple deletions and depletion of mitochondrial DNA. Semin Cell Biol Dev. 2001;12:417–427
  44. Clayton DA. Vertebrate mitochondrial DNA—a circle of suprises. Exp Cell Res. 2000;255:4–9
  45. Hoh IJ, Lorimer HE, Jacobs JT. Coupled leading and lagging-strand synthesis of mammalian mitochondrial DNA. Cell. 2000;100:515–524
  46. Yang MY, Bowmaker M, Reyes A, Vergani L, Angeli P, Gringeri E, et al. Biased incorporation of ribonucleotides on the mitochondrial L-strand accounts for apparent strand-asymmetric DNA replication. Cell. 2002;111:495–505
  47. Shoffner JM, Lott AS, Voljavec AS, et al. Spontaneous Kearns-Sayre/chronic progressive external ophthalmoplegia plus syndrome associated with a mitochondrial DNA deletion: a slip-replication model and metabolic therapy. Proc Natl Acad Sci USA. 1989;86:7952–7956
  48. Mita S, Rizzuto R, Moraes CT, Shanske S, Amaudo E, Fabrizi GM, et al. Recombination via flanking direct repeats is a major cause of large-scale deletions of human mitochondrial DNA. Nucleic Acids Res. 1990;18:561–567
  49. Poulton J, Deadman ME, Bindoff L, Morten K, Land J, Brown G. Families of mtDNA re-arrangement can be detected in patients with mtDNA deletions: duplications may be a transient intermediate form. Hum Mol Genet. 1993;2:23–30
  50. Lestienne P, Bataille N, Lucas-Heron B. Role of mitochondrial DNA and calmitine in myopathies. Biochim Biophys Acta. 1995;1271:159–163
  51. Wallace DG. Mitochondrial diseases: genotype versus phenotype. TIG. 1993;9:128–133
  52. Li JM, Cai Q, Zhou H, Xiao GX. Effects of hydrogen peroxide on mitochondrial gene expression of intestinal epithelial cells. World J Gastroenterol. 2002;8:1117–1122

PII: S0188-4409(06)00117-2

doi: 10.1016/j.arcmed.2006.03.007

Archives of Medical Research
Volume 37, Issue 7 , Pages 848-853 , October 2006

Article Tools

* Image Usage & Resolution